Upexi Inc. Common Stock (UPXI)

FairStock Score: 40/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable businesses selling at a discount to intrinsic value, and Upexi does not fit that description. It sells pet supplements under LuckyTail, energy solutions under PRAX, and functional mushrooms under Cure Mushrooms, plus it has a cryptocurrency cash-management angle. With only 10 employees and no evident pricing power, I see no clear moat. The filed record is troubling. In fiscal 2026, the year ended 2026-06-30, revenue was $17.4 million, net loss was $246.1 million, and diluted EPS was -$3.87. In fiscal 2025, the year ended 2025-06-30, revenue was $985,009 and net loss was $13.7 million. In fiscal 2024, the year ended 2024-06-30, revenue was $26.0 million and net loss was $23.7 million. Revenue is erratic, and losses are enormous. FairStock calculations at the 2026-10-13 close of $1.08 show a P/B of 1.86 and a negative P/E of -0.28. At that close, FairStock's trailing free cash flow was -$21.0 million and FCF yield was -23.7%. FairStock also calculates ROE of -468.50%, ROCE of -126.53%, and debt-to-equity of 4.38. The Piotroski score is 3/9 and the Altman Z-score is -1.98, both warning signs. FairStock's Lynch category is none because the company lost money in each of the last four years. A 44.19% revenue growth figure does not help when profit growth is -999.00% and owner earnings are deeply negative. The price may look low against book value, but book value is not reliable when losses compound. Without sustainable cash generation and a stronger balance sheet, this is speculation, not value.

In plain English: Upexi sells consumer products such as pet supplements, an energy product, and mushroom products, and it also has a cryptocurrency cash-management angle. The business looks weak: it has lost large amounts of money and burns cash. At the 2026-10-13 close of $1.08, the price does not look cheap compared with those losses; it looks speculative.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2026 10-Q (period ended 2025-12-31) · fiscal Q1 2026 10-Q (period ended 2025-09-30) · fiscal Q3 2025 10-Q (period ended 2025-03-31) · FY2026 10-K (period ended 2026-06-30) · FY2025 10-K (period ended 2025-06-30) · FY2024 10-K (period ended 2024-06-30)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer